Mode
Text Size
Log in / Sign up

Prolonged FVEP-P2 latency is associated with Alzheimer's disease and other forms of dementiaBrain Signal Delays Linked to Alzheimer's and Dementia Types

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that prolonged FVEP-P2 latency is associated with Alzheimer's and other dementias, but not yet established as a diagnostic tool.

This meta-analysis evaluated the association between flash visual evoked potential P2 latency (FVEP-P2) and various neurodegenerative conditions, including Alzheimer's disease (AD), mild cognitive impairment (MCI), vascular dementia (VaD), and progressive dementia (PDD). The study included 18 comparisons for AD and a total of 1,778 participants.

The primary finding was that FVEP-P2 latency was significantly prolonged in patients with AD compared to healthy controls (SMD = 1.55; 95% CI 1.05 to 2.05). Exploratory analyses indicated similar trends of increased latency in VaD (SMD = 1.44), MCI (SMD = 1.50), and PDD (SMD = 1.44). A restricted exploratory analysis for AD also showed significantly prolonged latency (SMD = 1.32; 95% CI 0.83 to 1.82).

The authors noted limitations including high heterogeneity in the AD (I2 = 88.9%) and VaD (I2 = 92.2%) groups, as well as potential small-study effects in the AD analysis. Because of the limited number of comparisons for VaD, MCI, and PDD, these findings are considered preliminary.

Clinically, while these results suggest a link between FVEP-P2 latency and cognitive decline, they do not establish a specific neurobiological mechanism or confirm its utility as a standalone diagnostic tool.

How this fits prior evidence

This meta-analysis provides an objective measure of physiological markers associated with dementia. While previous coverage has addressed risk factors such as diet, SGLT2 inhibitors, gabapentinoid use, and diabetic retinopathy, this study addresses a gap by examining neurophysiological indicators like FVEP-P2 latency in Alzheimer's disease and other forms of dementia.

Researchers looked at data from 1,778 people to see how the brain processes visual information. They specifically measured something called FVEP-P2 latency, which is a measure of how long it takes for the brain to respond to certain visual signals. This study included people with Alzheimer's disease, mild cognitive impairment, and vascular dementia.

The results showed that people with Alzheimer's disease had significantly longer signal delays compared to healthy individuals. The researchers also found similar patterns in people with other conditions like vascular dementia and progressive dementia. However, because the data for these specific groups came from a small number of comparisons, the findings are currently considered preliminary.

It is important to note that this study only shows a link between brain signals and these conditions. It does not explain exactly why this happens or prove that this test can be used as a primary way to diagnose dementia. Because there was a lot of variation in the data, more research is needed before these findings can change how doctors treat or diagnose patients.

What this means for you:
Delayed brain signals are linked to Alzheimer's and other dementias, but more research is needed for diagnosis.

Common questions

What did the study find about Alzheimer's?

The study found that people with Alzheimer's disease had significantly prolonged FVEP-P2 latency compared to healthy controls. This means their brains took longer to process specific visual signals. The results were consistent across several comparisons, showing a clear link between these delayed signals and the condition.

Can this test be used to diagnose dementia?

The study does not establish a diagnostic role for FVEP-P2 latency. While the results show a link between signal delays and conditions like vascular dementia and progressive dementia, the findings are preliminary because they were based on a small number of comparisons.

What other conditions were studied?

In addition to Alzheimer's disease, the study looked at patients with mild cognitive impairment, vascular dementia, and progressive dementia. In all three cases, the researchers found that these individuals showed prolonged signal delays compared to healthy people.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BackgroundThe flash visual evoked potential P2 component (FVEP-P2) has been investigated as a potential neurophysiological measure of cognitive impairment, but its biological and clinical significance remains uncertain. However, evidence remains fragmented. This systematic review and meta-analysis aimed to quantitatively synthesize evidence on FVEP-P2 latency alterations across the cognitive impairment continuum, including mild cognitive impairment (MCI) and major neurocognitive disorders (dementia).MethodsWe systematically searched PubMed, Embase, Web of Science, and Cochrane Library until July 28, 2025. Standardized mean differences (SMDs) for FVEP-P2 latency were pooled from 21 studies (n = 1,778) using a random-effects model to compare AD, mild cognitive impairment (MCI), and VaD groups against healthy controls (HC). Subgroup and sensitivity analyses explored heterogeneity sources.ResultsTwenty-one studies involving 1,778 participants were included. FVEP-P2 latency was significantly prolonged in patients with AD compared with healthy controls (18 comparisons, SMD = 1.55, 95% CI 1.05–2.05, I2 = 88.9%). Exploratory analyses also suggested prolonged latency in VaD (four comparisons; SMD = 1.44, 95% CI 0.35–2.53; I2 = 92.2%), MCI (two comparisons; SMD = 1.50, 95% CI 0.26–2.74; I2 = 53.8%), and PDD (one comparison; SMD = 1.44, 95% CI 0.63–2.25). In a restricted exploratory analysis excluding six selected AD comparisons, the association remained statistically significant and directionally consistent (SMD = 1.32, 95% CI 0.83–1.82; I2 = 84%). The ≥ 75-year subgroup showed lower heterogeneity (I2 = 41%), although differences between age subgroups were not statistically significant (p = 0.56). Funnel plot asymmetry and Egger’s test suggested potential small-study effects in the AD analysis.ConclusionProlonged FVEP-P2 latency was observed in AD, with preliminary findings suggesting similar alterations in other forms or stages of cognitive impairment. These findings do not establish a specific neurobiological mechanism or diagnostic role. Further studies are needed to clarify the biological basis and clinical value of FVEP-P2 latency.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.